As of 1:12:27 PM GMT+11. Market Open.
Research Analysis
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 2 | 3 |
Avg. Estimate | 0 | 0 | -0.1 | 0.06 |
Low Estimate | 0 | 0 | -0.1 | -0.08 |
High Estimate | 0 | 0 | -0.1 | 0.3 |
Year Ago EPS | -- | -- | -0.12 | -0.1 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 5 | 6 |
Avg. Estimate | 1.15M | 3.34M | 25.46M | 360.25M |
Low Estimate | -- | 2.41M | 8.69M | 44.05M |
High Estimate | 2.31M | 4.28M | 61.32M | 1.81B |
Year Ago Sales | -- | -- | 8.7M | 25.46M |
Sales Growth (year/est) | -- | -- | 192.69% | 1,314.69% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | -0.1 | 0.06 |
7 Days Ago | 0 | 0 | -0.02 | 0.05 |
30 Days Ago | 0 | 0 | -0.1 | -0.07 |
60 Days Ago | 0 | 0 | -0.1 | -0.07 |
90 Days Ago | 0 | 0 | -0.1 | -0.07 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 2 |
Up Last 30 Days | -- | -- | 1 | 2 |
Down Last 7 Days | -- | -- | 1 | -- |
Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MSB.AX | -- | -- | 11.87% | 153.94% |
S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
OCC.AX Orthocell Limited
1.0650
+6.50%
BOT.AX Botanix Pharmaceuticals Limited
0.3770
-0.79%
NEU.AX Neuren Pharmaceuticals Limited
13.26
-1.34%
IMU.AX Imugene Limited
0.0410
0.00%
CUV.AX Clinuvel Pharmaceuticals Limited
12.49
-1.26%
CU6.AX Clarity Pharmaceuticals Ltd
4.6300
-10.44%
PAR.AX Paradigm Biopharmaceuticals Limited
0.4300
-3.37%
IMM.AX Immutep Limited
0.3700
+4.23%
DXB.AX Dimerix Limited
0.3600
-4.00%
TLX.AX Telix Pharmaceuticals Limited
24.10
-0.21%